INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Outsourcing Patient Recruitment: What You Need To Know
Sponsors and CROs are increasingly outsourcing patient recruitment to specialized vendors to address the ongoing challenge of meeting initial recruitment targets on time.
-
What Sponsors Must Know To Safeguard Ocular Endpoints
Explore the necessity of incorporating imaging methodologies early in the trial design to improve data quality and overall trial efficiency.
-
We Made Five Predictions For Clinical Research Last Year. Here's What Happened
Review 2025’s gap between AI discovery and trial execution, highlighting legislative and FDA shifts to help sponsors operationalize participant experience for 2026.
-
Human Abuse Potential: Participant Safety
Explore how clinical staffing, monitoring equipment, and structured safety oversight support the safe conduct of Human Abuse Potential studies, including approaches to adverse event management.
-
Quotient Sciences Capacity Update July 20257/29/2025
Explore how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.
-
Big Futures For Emerging Biopharma: Navigating Biotech Hurdles1/14/2026
Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.
-
Clinical Trial Payments At Scale: Volume And Control2/4/2026
Find an operational explanation of what payment scale actually means in clinical trials, why small-study approaches break down, and how volume reshapes compliance, reporting, and automation decisions.
-
Enhancing Investigator Training And Communication During COVID-196/26/2024
Centralizing all trial-related information, enabling seamless interaction and global team coordination through Scout Academy.
-
High Density, Low Availability: Rethinking Ophthalmic Trial Readiness4/16/2025
The adoption of mobile ophthalmic solutions and collaboration with specialized vendors is recommended to ensure trial consistency and reach underserved regions.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Accelerate study start-up with the right sites, patients, and partnerships
As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.
-
Our site payments portal provides complete transparency, allowing you to fully outsource your payment operations to our experts or adopt a customizable hybrid model.
-
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
Our priority is guiding promising therapies to proof-of-concept with precision and urgency, because every day saved in development matters profoundly to patients living with cancer.
-
Unlock an enhanced customer experience through digital transformation by applying real-time visibility into your supply chain using cross-functional workflows and data-driven insights.